七彩化學(300758.SZ):上半年淨利預增20%-25%
格隆匯8月13日丨七彩化學(300758.SZ)公佈2021年半年度業績預吿,上半年歸屬於上市公司股東的淨利潤1.1-1.15億元,比上年同期增長20%-25%。
報吿期內,公司圍繞高性能有機顏料及材料單體業務為主線,持續加大研發經費投入(研發投入約增長71%),構築和提升了核心技術壁壘;在下游客户使用高性能有機顏料替代含鉛顏料的市場需求持續向好以及國外疫情蔓延,海外競爭對手產能受限的背景下,公司根據下游客户應用市場需求狀況,不斷優化產品結構及提供相關解決方案,市場份額得以顯著提升,凸顯了公司細分領域競爭實力,2021年半年度營業收入增長44%。
報吿期內,非經常性損益對公司淨利潤的影響金額約為3045.59萬元,主要為收到保險公司理賠款和對外投資產生的公允價值變動收益構成;上年同期非經常性損益金額為622.23萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.